REMEDENT USA INC/AZ
10QSB, EX-27, 2000-09-29
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: REMEDENT USA INC/AZ, 10QSB, 2000-09-29
Next: NET PERCEPTIONS INC, 8-K, 2000-09-29


WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
     THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM
FINANCIAL  STATEMENTS FOR THE QUARTER ENDING JUNE 30, 2000 AND JUNE 30, 1999 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>
<CIK>                         0001078037
<NAME>                        REMEDENT USA, INC.
<MULTIPLIER>                                   1
<CURRENCY>                                     U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              MAR-31-2000
<PERIOD-START>                                 APR-01-2000
<PERIOD-END>                                   JUN-30-2000
<EXCHANGE-RATE>                                1.000
<CASH>                                         14,869
<SECURITIES>                                   0
<RECEIVABLES>                                  57,422
<ALLOWANCES>                                   (3,000)
<INVENTORY>                                    109,643
<CURRENT-ASSETS>                               214,442
<PP&E>                                         58,810
<DEPRECIATION>                                 29,774
<TOTAL-ASSETS>                                 278,965
<CURRENT-LIABILITIES>                          919,332
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       12,579
<OTHER-SE>                                     (652,946)
<TOTAL-LIABILITY-AND-EQUITY>                   278,965
<SALES>                                        200,053
<TOTAL-REVENUES>                               200,053
<CGS>                                          69,865
<TOTAL-COSTS>                                  361,578
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             2,677
<INCOME-PRETAX>                                (164,134)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (164,134)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (164,134)
<EPS-BASIC>
<EPS-DILUTED>



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission